Home › Funds › INSTRUMENTAL WEALTH, LLC › SLS
INSTRUMENTAL WEALTH, LLC position in SLS
SELLAS LIFE SCIENCES GROUP I · Health Care
INSTRUMENTAL WEALTH, LLC reported holding 44,914 shares of SLS (SELLAS LIFE SCIENCES GROUP I) in its Q3 2026 13F filing — a position valued at US$553K, representing 0.27% of its reported portfolio and ranking #43 among its reported holdings. INSTRUMENTAL WEALTH, LLC has disclosed SLS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How INSTRUMENTAL WEALTH, LLC's SLS position evolved
INSTRUMENTAL WEALTH, LLC first disclosed a stake in SLS in Q3 2025 at 44,914 shares (US$86K). The position peaked in Q2 2026 at 44,914 shares, worth US$663K. Across 5 filings, INSTRUMENTAL WEALTH, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 44,914 shares valued at US$553K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 44.91K | $85.79K | New |
| Q4 2025 | 44.91K | $220.98K | Hold |
| Q1 2026 | 44.91K | $189.99K | Hold |
| Q2 2026 | 44.91K | $662.93K | Hold |
| Q3 2026 | 44.91K | $552.89K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP I) is a Health Care company. 106 other funds we track also report a position in SLS — the largest reported positions include Sio Capital Management, LLC (US$18.2M), DAGCO, INC. (US$16.5M), Anson Funds Management LP (US$11.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- Sio Capital Management, LLC 1.23M sh · $18.17M · Q2 2026
- DAGCO, INC. 1.34M sh · $16.45M · Q3 2026
- Anson Funds Management LP 800.00K sh · $11.81M · Q2 2026
- Ikarian Capital, LLC 354.70K sh · $5.24M · Q2 2026
- Opus Capital Group, LLC 403.63K sh · $4.97M · Q3 2026
- Rosalind Advisors, Inc. 568.70K sh · $2.30M · Q2 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K sh · $701.67K · Q3 2026
- Marathon Trading Investment Management LLC 50.10K sh · $616.73K · Q3 2026
More on INSTRUMENTAL WEALTH, LLC
FAQ
How long has INSTRUMENTAL WEALTH, LLC held SLS?
INSTRUMENTAL WEALTH, LLC has disclosed SLS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is INSTRUMENTAL WEALTH, LLC's current position in SLS?
As of Q3 2026, INSTRUMENTAL WEALTH, LLC holds 44.91K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $552.89K, representing 0.27% of its reported portfolio and ranking #43.
Has INSTRUMENTAL WEALTH, LLC been buying or selling SLS?
In the latest 13F filing (Q3 2026), INSTRUMENTAL WEALTH, LLC held unchanged its position in SLS. The position peaked in Q2 2026 at 44.91K shares.
Which other funds hold SLS?
Other major institutional holders of SLS include Sio Capital Management, LLC, DAGCO, INC., Anson Funds Management LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.